The earnings call presents a company facing significant challenges, including a decline in sales due to external economic conditions and hyperinflationary effects. However, the management's focus on cost-saving measures and strategic investments in growth initiatives highlights a proactive approach to overcoming these hurdles. The resilience of the EBITDA margin and strong historical growth provide a foundation for potential recovery.

Company Guidance

During Genomma Lab's Third Quarter 2025 Earnings Conference Call, the company provided detailed guidance and metrics despite facing a challenging environment. Sales grew nearly 70% over recent years, with EBITDA more than doubling and free cash flow surging by 152%, while earnings per share increased by 46%. However, the third quarter saw a 2.9% like-for-like sales decline, translating to a 12.8% decrease in Mexican pesos due to hyperinflationary accounting effects in Argentina. The EBITDA margin remained stable at 23.7%, consistent with the 24% target, highlighting strong cost discipline. The company aims to achieve MXN 3 billion in savings by 2026, reallocating MXN 1.1 billion into growth strategies. This investment focuses on product innovation, go-to-market efforts, and expanding distribution, with expectations to generate up to MXN 5 billion in additional sales opportunities for 2026-2027. Despite these challenges, Genomma remains confident in returning to growth by the first half of 2026, maintaining a healthier margin and cash flow structure.

Strong Historical Growth

Genomma Lab has experienced significant growth over the past few years, with sales up nearly 70%, EBITDA more than doubling, free cash flow surging 152%, and EPS increasing by 46%.

Resilient EBITDA Margin

Despite top-line headwinds, the company's EBITDA margin remains strong at around 24%, demonstrating effective cost discipline and efficiency programs.

Strategic Productivity Measures

Genomma Lab identified MXN 3 billion in savings by 2026, which includes an additional MXN 1.1 billion in efficiencies to be reinvested in growth strategies.

Expansion in Traditional and E-commerce Channels

The company plans to expand its traditional channel coverage from 730,000 to over 1 million points of sales and grow e-commerce sales to MXN 2 billion by 2027.

Genomma Lab Internacional SAB de CV (GNMLF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

GNMLF Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 25, 2026	2025 (Q4)	0.03 / -	0.025	―	―	―
Oct 23, 2025	2025 (Q3)	0.03 / 0.03	0.036	-4.55% (>-0.01)	―
Jul 23, 2025	2025 (Q2)	0.03 / 0.04	0.034	6.35% (<+0.01)	―
Apr 30, 2025	2025 (Q1)	0.02 / 0.03	0.019	38.89% (<+0.01)	―
Feb 27, 2025	2024 (Q4)	0.03 / 0.03	-0.006	527.27% (+0.03)	―
Oct 23, 2024	2024 (Q3)	0.03 / 0.04	0.021	70.10% (+0.01)	―
Jul 24, 2024	2024 (Q2)	0.02 / 0.03	0.021	58.29% (+0.01)	―
Apr 24, 2024	2024 (Q1)	0.02 / 0.02	0.018	5.57% (<+0.01)	―
Feb 22, 2024	2023 (Q4)	0.01 / >-0.01	0.013	-144.72% (-0.02)	―
Oct 25, 2023	2023 (Q3)	0.02 / 0.02	0.021	1.84% (<+0.01)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

GNMLF Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Oct 23, 2025	$0.94	$0.95	+1.06%
Jul 23, 2025	$1.11	$1.10	-0.90%
Apr 30, 2025	$1.22	$1.22	0.00%
Feb 27, 2025	$1.27	$1.21	-4.72%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Genomma Lab Internacional SAB de CV Class B (GNMLF) report earnings?

Genomma Lab Internacional SAB de CV Class B (GNMLF) is schdueled to report earning on Feb 25, 2026, After Close (Confirmed).

What is Genomma Lab Internacional SAB de CV Class B (GNMLF) earnings time?

Genomma Lab Internacional SAB de CV Class B (GNMLF) earnings time is at Feb 25, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is GNMLF EPS forecast?

GNMLF EPS forecast for the fiscal quarter 2025 (Q4) is 0.03.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing